Walter Brandner, MD
Adult Medicine · Birmingham, ALNPI 1932115763
Payments from drug & device makers
Across 647 payments — averaging $14.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$1K
- Lilly USA, LLC$764
- Amarin Pharma, Inc.$744
- GSK$712
- AstraZeneca$611
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 103 | $1,611 |
| AbbVie(2 entities) | 123 | $1,190 |
| Lilly USA, LLC | 53 | $764 |
| Amarin Pharma, Inc. | 53 | $744 |
| GSK | 44 | $712 |
| AstraZeneca | 41 | $611 |
| Pfizer | 37 | $546 |
| Abbott | 22 | $346 |
| Amgen(2 entities) | 20 | $336 |
| Johnson & Johnson | 16 | $264 |
| Boehringer Ingelheim | 14 | $257 |
| Merck | 15 | $224 |
| Astellas Pharma US Inc | 8 | $205 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $182 |
| Eisai Inc. | 10 | $155 |
| Esperion Therapeutics, Inc. | 9 | $143 |
| Novartis | 7 | $137 |
| Bayer | 8 | $135 |
| E.r. Squibb & Sons, L.L.C. | 6 | $111 |
| Dexcom, Inc. | 5 | $102 |
| Sanofi-aventis U.S. LLC | 5 | $93 |
| Teva Pharmaceuticals USA, Inc. | 6 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Boston Scientific | 4 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Exact Sciences | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Genentech USA, Inc. | 2 | $37 |
| Grifols USA, LLC | 2 | $34 |
| Shield Therapeutics Inc | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Biogen | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 2 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
How this compares
$9,486 in reported general payments places this provider in the 85th percentile of 26 adult medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult medicine in Birmingham
- Anthony ChestangBirmingham$5K
- Ayofemi WardBirmingham$24
- William SargeantMontgomery$1M
- Eyston HunteMobile$139K
- Delano BenjaminForestdale$10K
- Jeremy LedfordOpelika$9K
- Eric BeckerMobile$7K
- Jeremy AllenPell City$4K
- Adeel BodlaMadison$4K
- Yu-Yong Eugene TaiJasper$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.